Skip to main content
. Author manuscript; available in PMC: 2018 Apr 17.
Published in final edited form as: Immunol Rev. 2015 Sep;267(1):246–258. doi: 10.1111/imr.12329

Fig. 3. Divergence of the surfaces of Mamu-KIR3DL01 and human KIR3DL1 predicted to contact Bw4 ligands.

Fig. 3

(A) Alignment of five allotypes of Mamu-KIR3DL01 to human KIR3DL1 with residues predicted to contact MHC class I ligands based on the KIR3DL1-HLA-B*57 crystal structure shaded in gray (19, 53). (B) Surface projection of human KIR3DL1 with HLA-B*57-contact residues that are conserved in Mamu-KIR3DL01*001 indicated in red and residues that differ indicated in yellow (53). Copyright 2014. The American Association of Immunologists, Inc.